Paperback
Revolutionary cancer detection and treatment through liquid biopsy.

Liquid biopsy in Cancer Management

Integrating Diagnostics and Clinical Applications

  • Paperback

    498 pages

  • Release Date

    8 December 2025

Summary

Liquid Biopsy in Cancer Management: Integrating Diagnostics and Clinical Applications

This book provides a comprehensive overview of the rapidly evolving field of liquid biopsy, exploring its integration into cancer management from diagnostic capabilities to clinical applications. It delves into the fundamental principles behind liquid biopsy, detailing the various types of circulating biomarkers such as circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), and exosomes.

Book Details

ISBN-13:9780443274961
ISBN-10:0443274967
Author:Shvetank Bhatt, Kuttiappan Anitha, Santenna Chenchula, Neeraj Mishra
Publisher:Elsevier Science Publishing Co Inc
Imprint:Academic Press Inc
Format:Paperback
Number of Pages:498
Release Date:8 December 2025
Weight:450g
Dimensions:191mm x 235mm
A-Format
B-Format
C-Format
Liquid biopsy in Cancer Management by Shvetank Bhatt - ISBN: 9780443274961
191 × 235 mm
A4
mm / in
About The Author

Shvetank Bhatt

Author Biographies

Dr. Shvetank Bhatt is an Associate Professor in the School of Health Sciences and Technology at Dr. Vishwanath Karad MIT World Peace University, Pune, Maharashtra, India. He holds an M. Pharm degree in Pharmacology from Manipal College of Pharmaceutical Sciences and a Ph.D. in Neuropharmacology from Birla Institute of Technology & Science (BITS) Pilani. Dr. Bhatt specializes in CNS disorders, pain, inflammation, and immuno-oncology, with extensive industrial and academic research experience. He has received accolades such as the Prof. Duggirala Visweswaram & Prof. Sreemantalu Satyanarayana Award for Best Paper in Pharmacology-IJPER in 2012 and 2014. He has published numerous papers in national and international journals and is a life member of the Association of Pharmaceutical Teachers of India (APTI) and the Indian Pharmacological Society (IPS).

Dr. Kuttiappan Anitha is an Assistant Professor in the School of Pharmacy and Technology Management (SPTM), SVKM’s Narsee Monjee Institute of Management Studies (NMIMS) Deemed-to-University, Shirpur. She has broad teaching and research experience and received the “Excellence in Academic Award” 2022 from the International School of Technology and Sciences. Dr. Anitha has guided over 45 M.Pharm students and more than 10 batches of UG Projects. She has over 30 publications in national and international journals. Her areas of expertise include immuno-oncology, endocrine areas, gut microbiota, and infectious diseases. She has authored several books and book chapters and organized university-level conferences and seminars.

Dr. Santenna Chenchula is an academic faculty member and researcher in the Department of Pharmacology at the All India Institute of Medical Sciences (AIIMS) Bhopal. His research interests include clinical pharmacology, molecular medicine, precision medicine, pharmacogenomics, oncology, rational drug use, antimicrobial resistance, vaccines, drug discovery, clinical trials, and pharmacovigilance. He serves as a reviewer for several national and international biomedical research journals and has published dozens of articles. Dr. Chenchula has authored several books as the corresponding first author and is an active member of the Pharmacogenomics Research Network (PGRN), The American Society for Clinical Pharmacology and Therapeutics (ASCPT), and the Global Center for Evidence Synthesis (GCES). He is currently pursuing a PhD in clinical pharmacology, specializing in Precision Medicine and Pharmacogenomics.

Neeraj Mishra is Professor and Head of the Department of Pharmaceutics at the Amity Institute of Pharmacy, Amity University Madhya Pradesh, Gwalior, India. His academic work focuses on novel drug delivery systems, including localized, targeted, and controlled delivery approaches using nanocarrier and microparticle-based technologies. His research interests include therapies for cancer and neurodegenerative disorders, and he possesses extensive experience in teaching, research supervision, and scholarly publishing. He has also contributed to pharmaceutical sciences through intellectual property development and collaborative academic activities, supporting the advancement of drug delivery strategies and pharmaceutical research.

Returns

This item is eligible for free returns within 30 days of delivery. See our returns policy for further details.